Technetium-Bevacizumab in a Patient with Bone and Lung Metastatic Colon Adenocarcinoma

Journal of Clinical Oncology

Volumn 31, Issue 11, 2013, Pages

  Noguera, Eduardo C ^a   Palazzo, Emilio ^a   Mayoraz, Matias F ^a   Diller, Ana ^a   Burgesser, Maria V ^a   Jaime, Adelina ^a   Borello, Adriana ^a   Avila, Rodolfo ^a   Mondina, Juan C ^a  

^a HOSPITAL PRIVADO   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB TC 99M; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE BIOPSY; BONE METASTASIS; BONE SCINTISCANNING; CASE REPORT; COLON ADENOCARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL, HUMANIZED; BONE NEOPLASMS; COLONIC NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTEIN BINDING; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84876082375     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.44.0099     Document Type: Article

References (14)

1. Najafi A, Childs RL, Hnatowich DJ: Coupling antibody with DTPA: An alternative to the cyclic anhydride. Int J Appl Radiat Isot 35:554-557, 1984 (Pubitemid 14111737)
2. Gordon MS, Margolin K, Talpaz M, et al: Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer. J Clin Oncol 19:843-850, 2001 (Pubitemid 32119100)
3. Park SY, Kim HS, Hong EK, et al: Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum Pathol 33:1078-1085, 2002 (Pubitemid 35416704)
4. Stollman TH, Scheer MG, Leenders WP, et al: Specific imaging of VEGF-A expression with radiolabeled anti-VEGF monoclonal antibody. Int J Cancer 122:2310-2314, 2008 (Pubitemid 351542336)
5. Sundermeyer ML, Meropol NJ, Rogatko A, et al: Changing patterns of bone and brain metastases in patients with colorectal cancer. Clin Colorectal Cancer 5:108-113, 2005
6. Ellis LM, Takahashi Y, Liu W, et al: Vascular endothelial growth factor in human colon cancer: Biology and therapeutic implications. Oncologist 5:11-15, 2000 (suppl 1)
7. Dijkgraaf I, Boerman OC: Radionuclide imaging of tumor angiogenesis. Cancer Biother Radiopharm 24:637-647, 2009
8. Ferrara N, Hillan KJ, Gerber HP, et al: Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3:391-400, 2004 (Pubitemid 38618122)
9. Nagengast WB, de Vries EG, Hospers GA, et al: In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft. J Nucl Med 48:1313-1319, 2007 (Pubitemid 47242797)
10. Dijkgraaf I, Boerman OC: Molecular imaging of angiogenesis with SPECT. Eur J Nucl Med Mol Imaging 37:S104-S113, 2010 (suppl 1)
11. Khalil MM, Tremoleda JL, Bayomy TB, et al: Molecular SPECT imaging: An overview. Int J Mol Imaging [epub ahead of print on April 5, 2011]
12. Demir I, Muftuler FZB, Unak P, et al: In vivo investigation of radiolabeled bevacizumab in healthy rat tissues. Braz Arch Biol Technol 54:73-79, 2011
13. Filvaroff EH: VEGF and bone. J Musculoskelet Neuronal Interact 3:304-307, 2003
14. Guise TA, Mohammad KS, Clines G, et al: Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clin Cancer Res 12:6213s-6216s, 2006 (Pubitemid 44703792)